A nuclear factor-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates GVHD in allogeneic bone marrow transplantation-Reference-Cited by-同舟云学术

A nuclear factor-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates GVHD in allogeneic bone marrow transplantation

Published:2015-09 Issue:9 Volume:220 Page:1059-1066
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Yamanouchi Sohsaku,Adachi Yasushi,Shimo Tomohiko,Umezawa Kazuo,Okigaki Mitsuhiko,Tsuji Shoji,Li Ming,Takaya Junji,Kuge Tomohiro,Ikehara Susumu,Kaneko Kazunari

Funder

Mami Mizutani Foundation of Nakano Children's Hospital

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference45 articles.

1. Marked increase in number of dendritic cells in autoimmune-prone (NZW×BXSB)F1 mice with age;Adachi;Stem Cells,2002

2. Frequency and outcome of graft versus host disease after stem cell transplantation: a six-year experience from a tertiary care center in Pakistan;Ali;ISRN Hematol.,2013

3. Inhibition of tumor necrosis factor-alpha-induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin;Ariga;J. Biol. Chem.,2002

4. Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease;Baron;Transfusion (Paris),2000

5. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells;Barr;J. Exp. Med.,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Withania Somnifera Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia Effect;Cell Transplantation;2024-01

2. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect;International Immunopharmacology;2023-08

3. Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT;Frontiers in Immunology;2023-06-27

4. Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ;Cells;2021-09-01

5. 新しいNF-κB阻害剤・dehydroxymethylepoxyquinomicin（DHMEQ）の臨床応用への期待;The Journal of Kansai Medical University;2019